We identified 798 primary gliomas: 355 glioblastomas, 179 IDH1/2-mutant astrocytomas, 135 oligodendrogliomas, and 129 other IDH1/2-wild-type gliomas. This evidence concerns the gene IDH1 and central nervous system cancer.